Lifestyle Interventions for Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis, emerging as the leading cause of chronic liver pathology worldwide. Central to its management are lifestyle interventions aimed at sustained weight reduction, improved insulin sensitivity and mitigation of hepatic fat accumulation. Dietary strategies include structured caloric restriction, intermittent fasting patterns and macronutrient modification such as low-carbohydrate or Mediterranean-style regimens. Exercise prescription, combining aerobic and resistance training, augments lipid oxidation, reduces visceral adiposity and complements nutritional efforts. Behavioural support, delivered through regular clinic attendance or remote counselling, enhances adherence and long-term maintenance. Across diverse populations, a modest weight loss of 7–10 % is associated with marked reductions in steatosis, transaminase levels and fibrotic activity. Emerging approaches employ total diet replacement with stepwise reintroduction, very low-calorie ketogenic diets and targeted protein-rich meal replacements to accelerate fat mobilisation. As lifestyle measures remain the cornerstone in the absence of licensed pharmacotherapies for early disease, integration of dietary, exercise and behavioural components into personalised care plans is critical for global disease mitigation and prevention of cardiovascular comorbidity.

Research from Nature Portfolio

Large-scale observational analysis has defined a dose-response relationship between body mass index and fatty liver risk, demonstrating a nonlinear increase in steatosis prevalence with progressive overweight and obesity. This foundational study underscores the imperative of early weight management to avert the onset of NAFLD. A randomised controlled trial of modified alternate-day calorie restriction revealed significant reductions in hepatic steatosis, liver enzymes and fibrosis markers compared with habitual diet, while maintaining high adherence over eight weeks. Intermittent fasting implemented as alternate-day energy restriction yielded marked improvements in ultrasound-assessed fat content and elastography measurements, establishing its efficacy as a practical dietary intervention.

Lifestyle Interventions for Nonalcoholic Fatty Liver Disease publication trend

The graph below shows the total number of articles in lifestyle interventions for nonalcoholic fatty liver disease across all publications each year (not limited to Nature Index journals).

Technical terms

Nonalcoholic fatty liver disease (NAFLD): A spectrum of liver disorders characterised by excess fat accumulation in hepatocytes unrelated to significant alcohol intake.

Nonalcoholic steatohepatitis (NASH): An advanced NAFLD stage involving inflammation and hepatocellular injury, with or without fibrosis.

Calorie restriction: Reduction of daily energy intake below usual requirements to induce weight loss and metabolic improvements.

Intermittent fasting: Dietary pattern alternating periods of minimal or zero caloric intake with periods of normal eating.

Very low-calorie ketogenic diet (VLCKD): A nutritional regimen providing very low carbohydrates to induce ketosis, promoting rapid fat loss.

Hepatic steatosis: Accumulation of lipids within liver cells, detectable by imaging or histology.

Total diet replacement: A structured programme in which conventional meals are fully replaced by nutritionally complete formula products for a defined period.

References

1. Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis. Gut Microbes (2024).
2. Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Controlled Trial. Journal of Cachexia Sarcopenia and Muscle (2025).
3. Association between body mass index and fatty liver risk: A dose-response analysis. Scientific Reports (2018).
4. A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. Scientific Reports (2019).